MetLife, Inc. (NYSE:MET) Shares Sold by Moody National Bank Trust Division

Moody National Bank Trust Division trimmed its stake in MetLife, Inc. (NYSE:METFree Report) by 2.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,807 shares of the financial services provider’s stock after selling 384 shares during the quarter. Moody National Bank Trust Division’s holdings in MetLife were worth $1,131,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Dimensional Fund Advisors LP raised its holdings in MetLife by 22.4% during the 2nd quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after buying an additional 988,666 shares during the period. Legal & General Group Plc increased its position in shares of MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock worth $371,993,000 after acquiring an additional 269,246 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after acquiring an additional 68,579 shares during the period. Nordea Investment Management AB lifted its position in shares of MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its stake in MetLife by 3.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 3,224,930 shares of the financial services provider’s stock worth $226,358,000 after purchasing an additional 100,782 shares during the period. 94.99% of the stock is owned by institutional investors and hedge funds.

MetLife Stock Up 2.1 %

MetLife stock opened at $81.94 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. MetLife, Inc. has a 1-year low of $64.61 and a 1-year high of $89.05. The firm’s fifty day simple moving average is $83.04 and its 200-day simple moving average is $79.11. The company has a market capitalization of $56.74 billion, a P/E ratio of 16.52, a P/E/G ratio of 0.76 and a beta of 1.07.

MetLife Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.66%. MetLife’s dividend payout ratio is currently 43.95%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on MET. TD Cowen increased their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Wells Fargo & Company increased their price objective on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Jefferies Financial Group raised their price objective on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Finally, Barclays raised their price target on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $90.00.

Get Our Latest Research Report on MET

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.